Skip to main content
IDEXX LABORATORIES INC /DE logo

IDEXX LABORATORIES INC /DE — Investor Relations & Filings

Ticker · IDXX ISIN · US45168D1046 LEI · OGMTXK0LUU1HKV2P0J84 US Professional, scientific and technical activities
Open in API
Filings indexed 1,395 across all filing types
Latest filing 2019-07-18 Director's Dealing
Country US United States of America
Listing US IDXX

About IDEXX LABORATORIES INC /DE

https://www.idexx.com/

IDEXX Laboratories, Inc. is a global leader in diagnostics and software for the veterinary, livestock, and water testing markets. The company develops, manufactures, and distributes a broad range of products and services aimed at enhancing the health and well-being of pets, people, and livestock. Core offerings include in-clinic point-of-care diagnostic instruments and tests, a global network of reference laboratories providing advanced testing services, and practice management software solutions for veterinarians. These integrated solutions provide veterinarians with actionable insights to deliver advanced medical care and improve practice efficiency.

Recent filings

Filing Released Lang Actions
FORM 3
Director's Dealing
2019-07-18 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K current report filed with the SEC by IDEXX Laboratories, Inc. The key content is the election of a new director, Sam Samad, to the company's board of directors. The document details the board's decision, the increase in board size, compensation details, and references a press release about the election. There is no financial data or report content, only an announcement of a board/management change. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is just over 5,000 characters but the content clearly fits the MANG category rather than any financial report or other category.
2019-07-18 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce significant events. The content specifically announces the departure (medical leave of absence) of the company's Chairman, President, and CEO, and the appointment of an interim CEO. This matches the description of Board/Management Information filings, which cover announcements of changes in the company's board of directors or senior management. The document does not contain financial statements or detailed financial data, so it is not an Annual Report or Interim Report. It is not a report publication announcement or regulatory filing in the fallback sense, but a direct announcement of management changes.
2019-07-01 English
FORM 4
Director's Dealing
2019-06-04 English
FORM 4
Director's Dealing
2019-06-04 English
SD
Regulatory Filings Classification · 95% confidence The document is a Form SD filed with the SEC, specifically a Specialized Disclosure Report related to conflict minerals for the calendar year ended December 31, 2018. It references a Conflict Minerals Report as an exhibit and provides information about the reporting period and regulatory rule (Rule 13p-1 under the Securities Exchange Act). The document length is 2775 characters, which is relatively short and primarily serves as a disclosure filing rather than a full report. It does not contain comprehensive financial data or detailed analysis but rather references an attached report. Therefore, this document fits the category of Regulatory Filings (RNS), which is the fallback for specialized regulatory disclosures that do not fit other categories like Annual Report or Interim Report.
2019-05-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.